Felix Ehret
@felixehretmd.bsky.social
MD, MS | Radiation Oncology | Charité - Universitätsmedizin Berlin
Our new ESTRO CNS Focus Group analysis uncovers how reirradiation is used in primary brain tumors – read the full paper: www.thegreenjournal.com/article/S016...
@estroradiotherapy.bsky.social @eanoassociation.bsky.social @astro-org.bsky.social @neuroonc.bsky.social @andradaturcas.bsky.social
@estroradiotherapy.bsky.social @eanoassociation.bsky.social @astro-org.bsky.social @neuroonc.bsky.social @andradaturcas.bsky.social
Patterns of care in primary brain tumour Reirradiation: A survey by the ESTRO CNS focus Group
Radiotherapy (RT) remains a cornerstone in the management of primary brain tumours.
However, recurrences within previously irradiated volumes present a complex clinical
challenge. In the absence of an...
www.thegreenjournal.com
November 23, 2025 at 7:31 PM
Our new ESTRO CNS Focus Group analysis uncovers how reirradiation is used in primary brain tumors – read the full paper: www.thegreenjournal.com/article/S016...
@estroradiotherapy.bsky.social @eanoassociation.bsky.social @astro-org.bsky.social @neuroonc.bsky.social @andradaturcas.bsky.social
@estroradiotherapy.bsky.social @eanoassociation.bsky.social @astro-org.bsky.social @neuroonc.bsky.social @andradaturcas.bsky.social
Can DNA methylation risk groups unlock personalized radiotherapy decisions in meningioma? Our new paper provides the clinical framework — thanks to all collaborators! @neuroonc.bsky.social @eanoassociation.bsky.social @gelarehzadeh.bsky.social @icomeningioma.bsky.social
doi.org/10.1093/neuo...
doi.org/10.1093/neuo...
A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma
AbstractBackground. DNA methylation profiling can be used to robustly predict postsurgical outcomes and response to radiotherapy (RT) for meningioma patien
doi.org
November 20, 2025 at 9:29 AM
Can DNA methylation risk groups unlock personalized radiotherapy decisions in meningioma? Our new paper provides the clinical framework — thanks to all collaborators! @neuroonc.bsky.social @eanoassociation.bsky.social @gelarehzadeh.bsky.social @icomeningioma.bsky.social
doi.org/10.1093/neuo...
doi.org/10.1093/neuo...
#EANO2025 comes to an end - it was a fantastic conference, thanks to everyone who participated and made it possible! See you next year in Rome! @eanoassociation.bsky.social @maxmastall.bsky.social @mj-mair.bsky.social @galldiks.bsky.social @profajchalmers.bsky.social
October 19, 2025 at 11:21 AM
#EANO2025 comes to an end - it was a fantastic conference, thanks to everyone who participated and made it possible! See you next year in Rome! @eanoassociation.bsky.social @maxmastall.bsky.social @mj-mair.bsky.social @galldiks.bsky.social @profajchalmers.bsky.social
The final day of #EANO2025 starts with the general assembly! Wonderful to see how well each committee is doing, thank you very much! @eanoassociation.bsky.social @galldiks.bsky.social @mj-mair.bsky.social @maxmastall.bsky.social @profajchalmers.bsky.social @jmwerner.bsky.social
October 19, 2025 at 6:16 AM
The final day of #EANO2025 starts with the general assembly! Wonderful to see how well each committee is doing, thank you very much! @eanoassociation.bsky.social @galldiks.bsky.social @mj-mair.bsky.social @maxmastall.bsky.social @profajchalmers.bsky.social @jmwerner.bsky.social
Lively debates and sharp arguments at the #EANO2025 Youngsters Pro&Con Session - informative, entertaining, and full of expert insights, this is what scientific exchange should look like! #NeuroOncology @eanoassociation.bsky.social @maxmastall.bsky.social @galldiks.bsky.social
October 18, 2025 at 3:32 PM
Lively debates and sharp arguments at the #EANO2025 Youngsters Pro&Con Session - informative, entertaining, and full of expert insights, this is what scientific exchange should look like! #NeuroOncology @eanoassociation.bsky.social @maxmastall.bsky.social @galldiks.bsky.social
We had a brilliant #EANO2025 Youngsters and CBI session with countless helpful tricks for young investigators! @eanoassociation.bsky.social @maxmastall.bsky.social @mj-mair.bsky.social @galldiks.bsky.social @profajchalmers.bsky.social
October 18, 2025 at 12:20 PM
We had a brilliant #EANO2025 Youngsters and CBI session with countless helpful tricks for young investigators! @eanoassociation.bsky.social @maxmastall.bsky.social @mj-mair.bsky.social @galldiks.bsky.social @profajchalmers.bsky.social
Reposted by Felix Ehret
The second day of EANO 2025 in Prague begins – featuring a full schedule of high-level science, clinical innovation, and exchange across all disciplines in #NeuroOncology.
See what’s on today 👉 eano.eu/eano2025/pro...
#Immuntherapy #Gliom #Neurosurgery #Youngsters #Radiotherapy #FamilyFocusedCare
See what’s on today 👉 eano.eu/eano2025/pro...
#Immuntherapy #Gliom #Neurosurgery #Youngsters #Radiotherapy #FamilyFocusedCare
October 18, 2025 at 6:18 AM
The second day of EANO 2025 in Prague begins – featuring a full schedule of high-level science, clinical innovation, and exchange across all disciplines in #NeuroOncology.
See what’s on today 👉 eano.eu/eano2025/pro...
#Immuntherapy #Gliom #Neurosurgery #Youngsters #Radiotherapy #FamilyFocusedCare
See what’s on today 👉 eano.eu/eano2025/pro...
#Immuntherapy #Gliom #Neurosurgery #Youngsters #Radiotherapy #FamilyFocusedCare
The next day of #EANO2025 starts with many valuable insights from the EANO Youngsters-EORTC session on clinical trials! @eanoassociation.bsky.social
October 18, 2025 at 7:16 AM
The next day of #EANO2025 starts with many valuable insights from the EANO Youngsters-EORTC session on clinical trials! @eanoassociation.bsky.social
Today‘s sessions on intraoperative diagnostics and radiation therapy for gliomas at #EANO2025 were highly informative! @eanoassociation.bsky.social @profajchalmers.bsky.social
October 17, 2025 at 5:47 PM
Today‘s sessions on intraoperative diagnostics and radiation therapy for gliomas at #EANO2025 were highly informative! @eanoassociation.bsky.social @profajchalmers.bsky.social
The opening plenary session at #EANO2025 highlighted some of the considerable advances made in the field! @eanoassociation.bsky.social
October 17, 2025 at 1:28 PM
The opening plenary session at #EANO2025 highlighted some of the considerable advances made in the field! @eanoassociation.bsky.social
Storytelling matters! We had a great session about the importance of storytelling in #NeuroOncology at #EANO2025 @eanoassociation.bsky.social @mj-mair.bsky.social @maxmastall.bsky.social @galldiks.bsky.social
October 17, 2025 at 9:53 AM
Storytelling matters! We had a great session about the importance of storytelling in #NeuroOncology at #EANO2025 @eanoassociation.bsky.social @mj-mair.bsky.social @maxmastall.bsky.social @galldiks.bsky.social
Last night‘s #EANO2025 reception was a blast - lots of opportunities to connect and reconnect with so many great people in the field! @eanoassociation.bsky.social @mj-mair.bsky.social @mj-mair.bsky.social @profajchalmers.bsky.social @apellerino85.bsky.social @galldiks.bsky.social
October 17, 2025 at 6:38 AM
Last night‘s #EANO2025 reception was a blast - lots of opportunities to connect and reconnect with so many great people in the field! @eanoassociation.bsky.social @mj-mair.bsky.social @mj-mair.bsky.social @profajchalmers.bsky.social @apellerino85.bsky.social @galldiks.bsky.social
#EANO2025 is starting off strong with the Educational Day, featuring the clinical, basic science, and supportive care tracks! #NeuroOncology @eanoassociation.bsky.social @maxmastall.bsky.social @jmwerner.bsky.social @profajchalmers.bsky.social @apellerino85.bsky.social @galldiks.bsky.social
October 16, 2025 at 10:48 AM
#EANO2025 is starting off strong with the Educational Day, featuring the clinical, basic science, and supportive care tracks! #NeuroOncology @eanoassociation.bsky.social @maxmastall.bsky.social @jmwerner.bsky.social @profajchalmers.bsky.social @apellerino85.bsky.social @galldiks.bsky.social
Reposted by Felix Ehret
👉 We are very proud to present our #EANO2025 ambassadors! Follow them on LinkedIn a/o Bluesky for a range of expert insights & join the conversation using the official hashtag #EANO2025.
We look forward to meeting you all in #Prague!
#NeuroOncology #btsm
We look forward to meeting you all in #Prague!
#NeuroOncology #btsm
October 15, 2025 at 12:24 PM
👉 We are very proud to present our #EANO2025 ambassadors! Follow them on LinkedIn a/o Bluesky for a range of expert insights & join the conversation using the official hashtag #EANO2025.
We look forward to meeting you all in #Prague!
#NeuroOncology #btsm
We look forward to meeting you all in #Prague!
#NeuroOncology #btsm
Excited to share our latest @ijrobp.bsky.social paper on modeling brain necrosis progression based on vascular heterogeneity! Huge congrats to the team for this accomplishment! @astro-org.bsky.social @estroradiotherapy.bsky.social @eanoassociation.bsky.social
www.redjournal.org/article/S036...
www.redjournal.org/article/S036...
A mechanistic model of brain necrosis progression based on vascular heterogeneity
Brain radionecrosis (RN) is a significant late toxicity of radiation therapy, yet
its progression remains challenging to predict due to patient-specific factors. This
study develops a mechanistic mode...
www.redjournal.org
October 11, 2025 at 7:12 PM
Excited to share our latest @ijrobp.bsky.social paper on modeling brain necrosis progression based on vascular heterogeneity! Huge congrats to the team for this accomplishment! @astro-org.bsky.social @estroradiotherapy.bsky.social @eanoassociation.bsky.social
www.redjournal.org/article/S036...
www.redjournal.org/article/S036...
Had a fantastic time at #ASTRO2025 in San Francisco - grateful for the chance to reconnect with colleagues, collaborators, and friends from around the world! @astro-org.bsky.social @ucsfradonc.bsky.social @ruehlealex.bsky.social
October 2, 2025 at 2:36 AM
Had a fantastic time at #ASTRO2025 in San Francisco - grateful for the chance to reconnect with colleagues, collaborators, and friends from around the world! @astro-org.bsky.social @ucsfradonc.bsky.social @ruehlealex.bsky.social
Excited to share our latest work on TERT mutations in meningiomas, just published in @thelancetoncol.bsky.social! A huge thanks to the team! @neuroonc.bsky.social @eanoassociation.bsky.social @icomeningioma.bsky.social
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis
The indolent behaviour of certain TERTp-mutant meningiomas suggests that TERTp mutation
is not sufficient to assign the most aggressive meningioma grade. Instead, TERT sequencing
might offer prognosti...
www.thelancet.com
September 2, 2025 at 1:32 PM
Excited to share our latest work on TERT mutations in meningiomas, just published in @thelancetoncol.bsky.social! A huge thanks to the team! @neuroonc.bsky.social @eanoassociation.bsky.social @icomeningioma.bsky.social
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...
Treating adrenal gland metastases with SBRT? Check out our latest guide - huge thanks to all collaborators! @estroradiotherapy.bsky.social @astro-org.bsky.social
www.practicalradonc.org/article/S187...
www.practicalradonc.org/article/S187...
Stereotactic Body Radiotherapy for the Treatment of Adrenal Metastases – A Case-Based Radiosurgery Society Practice Guide and Review
Adrenal metastases are frequently diagnosed in patients with common solid tumors.
Surgical adrenalectomy has historically been used for their management. However, stereotactic
body radiotherapy (SBRT)...
www.practicalradonc.org
July 13, 2025 at 2:14 PM
Treating adrenal gland metastases with SBRT? Check out our latest guide - huge thanks to all collaborators! @estroradiotherapy.bsky.social @astro-org.bsky.social
www.practicalradonc.org/article/S187...
www.practicalradonc.org/article/S187...
The extent of resection in brain metastases plays a critical role – but how impactful is it? Dive into our latest analysis, featuring data from 867 patients!
journals.lww.com/neurosurgery...
journals.lww.com/neurosurgery...
Impact of Extent of Resection on Survival in Brain... : Neurosurgery
group.
METHODS:
We included patients who underwent BM resection and had postoperative MRI <72 hours. Presence of any residual on MRI was defined as subtotal resection (STR) as opposed to gross tota...
journals.lww.com
June 23, 2025 at 2:56 PM
The extent of resection in brain metastases plays a critical role – but how impactful is it? Dive into our latest analysis, featuring data from 867 patients!
journals.lww.com/neurosurgery...
journals.lww.com/neurosurgery...
What’s the role of radiosurgery in pediatric patients with CNS lesions? Here’s our first multicenter study! @estroradiotherapy.bsky.social
www.thegreenjournal.com/article/S016...
www.thegreenjournal.com/article/S016...
Radiosurgery for pediatric central nervous system lesions – initial report and insights from a multicenter registry
Stereotactic radiosurgery (SRS) is an established treatment modality for a variety
of benign and malignant central nervous system (CNS) lesions in adults [1,2]. However,
data for its use in the pediat...
www.thegreenjournal.com
June 21, 2025 at 11:34 PM
What’s the role of radiosurgery in pediatric patients with CNS lesions? Here’s our first multicenter study! @estroradiotherapy.bsky.social
www.thegreenjournal.com/article/S016...
www.thegreenjournal.com/article/S016...
Reirradiation with SRS for vestibular schwannomas – how effective and safe is it? Check out our latest systematic review & meta-analysis! @estroradiotherapy.bsky.social
www.ctro.science/article/S240...
www.ctro.science/article/S240...
Reirradiation with stereotactic radiosurgery for vestibular schwannomas – a systematic review and meta-analysis
Vestibular schwannomas (VS), also known under the historical misnomer “acoustic neuroma”,
are benign nerve sheath tumors that develop from the Schwann cells of the vestibular
branch of the vestibuloco...
www.ctro.science
June 18, 2025 at 9:13 PM
Reirradiation with SRS for vestibular schwannomas – how effective and safe is it? Check out our latest systematic review & meta-analysis! @estroradiotherapy.bsky.social
www.ctro.science/article/S240...
www.ctro.science/article/S240...
Just published: Our early experience with proton CSI for LMD from solid tumors in adults - now online! @eanoassociation.bsky.social @neuroonc.bsky.social
doi.org/10.1186/s130...
doi.org/10.1186/s130...
Early experience with proton craniospinal irradiation in adult patients with leptomeningeal disease - Radiation Oncology
Background Leptomeningeal disease (LMD) is a fatal complication of cancer linked to poor survival rates and limited treatment options. While photon involved-field radiotherapy is the standard of care ...
doi.org
April 23, 2025 at 12:34 AM
Just published: Our early experience with proton CSI for LMD from solid tumors in adults - now online! @eanoassociation.bsky.social @neuroonc.bsky.social
doi.org/10.1186/s130...
doi.org/10.1186/s130...
Reposted by Felix Ehret
@felixehretmd.bsky.social is a research fellow at MGH and @harvardmed.bsky.social, as well as a #RadiationOncology resident @ChariteBerlin. His research focuses on refining and personalizing radiation therapy for various #BrainTumors, including gliomas, brain metastases, and #meningiomas.
April 7, 2025 at 9:35 AM
@felixehretmd.bsky.social is a research fellow at MGH and @harvardmed.bsky.social, as well as a #RadiationOncology resident @ChariteBerlin. His research focuses on refining and personalizing radiation therapy for various #BrainTumors, including gliomas, brain metastases, and #meningiomas.
What do 1p losses and 1q gains mean for meningiomas? Read our latest study in JAMA Oncology! Huge thanks to everyone involved!
@gelarehzadeh.bsky.social @icomeningioma.bsky.social
jamanetwork.com/journals/jam...
@gelarehzadeh.bsky.social @icomeningioma.bsky.social
jamanetwork.com/journals/jam...
Chromosome 1p Loss and 1q Gain for Grading of Meningioma
This cohort study examines chromosomal copy number alterations that could be used to improve the current World Health Organization grading of meningioma
jamanetwork.com
April 3, 2025 at 11:42 PM
What do 1p losses and 1q gains mean for meningiomas? Read our latest study in JAMA Oncology! Huge thanks to everyone involved!
@gelarehzadeh.bsky.social @icomeningioma.bsky.social
jamanetwork.com/journals/jam...
@gelarehzadeh.bsky.social @icomeningioma.bsky.social
jamanetwork.com/journals/jam...
As every year, the RSS annual meeting was a wonderful opportunity to connect with both old and new friends and collaborators!
March 22, 2025 at 9:35 PM
As every year, the RSS annual meeting was a wonderful opportunity to connect with both old and new friends and collaborators!